mRNA COVID-19 Booster Outperforms Protein-Based Shot on Antibodies, But Both Cut Infections Over 12 Months

Publication date: Jul 23, 2026

Neutralizing antibody results tracked closely with the binding-antibody findings, but IGRA responses did not differ significantly between the 2 vaccine groups at either timepoint. A self-selected control group of 143 adults who did not receive a fourth dose were also followed.

Concepts Keywords
Australia Adults
Immunocompromised Antibody
June Based
Low Booster
Boosters
Covid
Dose
Fourth
Group
Higher
Moderna
Months
Mrna
Protein
Vaccine

Semantics

Type Source Name
disease MESH Infections
disease MESH COVID-19

(Visited 6 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *